ClinicalTrials.gg
RecruitingNCT05399056ImPReSS-COPDUpdated Jun 5, 2026

Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling

An interventional study of Telephonic Peer Coaching and Storytelling in Chronic Obstructive Pulmonary Disease, sponsored by Baystate Medical Center. Recruiting at 1 site in United States. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-06-05.

Sponsored by Baystate Medical Center · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Feb 2023; still recruiting 3 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
305
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

Chronic Obstructive Pulmonary Disease (COPD) affects approximately 16 million Americans and is characterized by recurrent exacerbations that lead to 1.5 million Emergency Department visits and 700,000 hospitalizations annually. Pulmonary rehabilitation (PR) is a structured program of exercise and self-management support that has been proven to relieve shortness of breath and increase quality of life when initiated after an exacerbation, but unfortunately, few eligible patients participate. This project will compare the effectiveness of two novel strategies - one involving video narratives of other patients telling their story of how they overcame challenges and completed PR, the other involving telephonic peer coaching with an individual with lived experience - to enhanced usual care, and to each other, at increasing patient participation in PR after an exacerbation.

Read the detailed description

Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) lead to roughly 1.5 million ED visits and 700,000 hospitalizations annually. Recovery is slow and accompanied by high levels of acute care utilization and mortality. Pulmonary Rehabilitation (PR) is a structured program of exercise and self-management support that has been shown to relieve dyspnea and improve quality of life. Clinical guidelines recommend PR for patients with stable COPD and after an exacerbation. Unfortunately, even when referred by physicians, research has shown that few patients who might benefit from PR ever begin treatment.

The primary goal of this project is to identify effective strategies for promoting and sustaining participation in PR. Peer Support involves pairing a patient with a trained peer from a similar background, and facing similar health challenges, who has completed PR. There is a growing body of evidence demonstrating the feasibility, acceptability, and effectiveness of telephonic peer support for chronic disease management. Narrative interventions, or 'Storytelling', are novel approaches for changing attitudes and behaviors of patients that involve creating and disseminating videos narrated by individuals with lived experience with the same condition or facing the same treatment. Storytelling interventions have been shown to help individuals achieve better blood pressure control, and storytelling is being studied in a variety of other clinical contexts.

In the R61 Phase, the investigators will recruit and train a cohort of peer coaches in behavior change techniques, and will recruit a diverse group of storytellers, capture their narratives on video, and create a library of 6-8 powerful stories. The investigators will finalize the protocol, trial infrastructure, and pilot the recruitment strategy. During the R33 Phase, the investigators will recruit 305 adults treated for exacerbation of COPD, and randomize them to 1) Enhanced "Usual Care" (eUC); 2) eUC + Storytelling; or 3) eUC + Peer Support. The investigators will evaluate the effectiveness of each strategy compared to eUC, and to each other, at promoting participation in PR at 6 months.

Using a mixed-methods approach, the investigators will evaluate intervention acceptability, sustainability, and cost, from the perspectives of the patients and peer coaches as well as PR program staff and hospital leadership. This information will be uses to refine the strategies and to disseminate an implementation package that will enable other PR programs to adopt these approaches.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disease

Keywords

  • COPD
  • Pulmonary rehabilitation
  • Storytelling
  • Peer coaching
  • motivational interviewing
  • Behavioral interventions
  • chronic obstructive pulmonary disease
03

In context

Pulmonary Disease, Chronic Obstructive

5,520 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 856 are open to participants now.

This study's planned enrollment of 305 is above the median of 62 across 3,839 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.

Browse Pulmonary Disease, Chronic Obstructive studies →

Lead sponsor

Baystate Medical Center is the lead sponsor of 48 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 40 years or older
  • Received treatment for exacerbation in either inpatient or outpatient setting
  • Referred for pulmonary rehabilitation
  • Ability to understand and communicate in English
  • Willingness to participate in calls with peer coach and to view storytelling videos
  • Working phone

Exclusion criteria

Exclusion Criteria:

  • Unwilling to attend PR
  • Not eligible for PR based on spirometry or other clinical as determined by PR staff
  • Currently enrolled in, or completion of 12 or more sessions of PR in the past
  • Comfort measures only or Hospice care
  • Resident of long-term care facility
  • Unable or unwilling to give
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
305 participants (estimated)

Study arms

  • No intervention
    Enhanced usual care

    Enhanced usual care describes a process in which automated surveillance is used to identify individuals experiencing a COPD exacerbation. This is followed by direct outreach - either through in-person visits while a patient is hospitalized, or by mail and telephone in the outpatient setting, to facilitate referral to PR. Subjects randomized to this arm will be given a pamphlet describing the benefits of PR.

  • Active comparator
    Enhanced usual care + Storytelling

    Subjects randomized to the eUC + Storytelling intervention will view the video narrative(s) of one or more individuals with COPD who has overcome similar barriers and has attended a program of PR. Subjects will be shown the first chapter of the story immediately after randomization and will receive email and/or text messages to prompt viewing of subsequent chapters at 2 weeks, 1 month, 2 months, 3 months and 5 months. Emails and text messages will include a link to a REDCap document that contains a set of embedded video clips representing the next chapter in each storyteller's narrative.

    Behavioral: Storytelling

  • Active comparator
    Enhanced usual care + Peer support

    Subjects randomized to the eUC + Peer support intervention will be matched with a peer coach of the same gender, race, and approximate age. For those enrolled during a hospitalization, coaches will be instructed to attempt the initial phone contact prior to the patient's discharge; for patients enrolled after an ED visit or outpatient exacerbation, coaches will be instructed to contact the patients within 72 hours of randomization. Peer coaches will be asked to complete at least one call each week during months 1-2, biweekly calls during months 3-4, and monthly calls during months 5-6. Coaches will be asked to follow a conversation guide, provided during the initial training, to structure phone conversations with their paired patient.

    Behavioral: Telephonic Peer Coaching

Interventions

  • BehavioralTelephonic Peer Coaching

    Telephonic Peer Coaching from an individual with lived experience with COPD and Pulmonary Rehabilitation trained in motivational interviewing

  • BehavioralStorytelling

    Video narratives of an individual with lived experience with COPD and Pulmonary Rehabilitation describing their journey through Pulmonary Rehabilitation

06

What researchers measure

Primary outcomes

  1. Number of Pulmonary Rehabilitation (PR) sessions: Completion of ≥6 PR sessions within 6 months of randomization

    Time frame: 6 months

Secondary outcomes

  1. Any attendance (yes/no) at PR within 6 months of randomization.

    Time frame: 6 months

  2. Total number of PR sessions completed within 6 months of randomization.

    Time frame: 6 months

  3. Time to first PR session attended

    Time frame: 6 months

Other outcomes

  1. Change in Modified Medical Research Council (mMRC) dyspnea scale from randomization to 6 months

    Time frame: 6 months

  2. Change in Clinical COPD Questionnaire (CCQ) from randomization to 6 months

    Time frame: 6 months

  3. Change in Hospital Anxiety and Depression Scale (HADS) from randomization to 6 months

    Time frame: 6 months

  4. Activation (Self Efficacy for Managing Chronic Diseases 6)

    Time frame: 6 months

  5. Change in Medical Outcomes Survey (MOS) Social Support Survey from randomization to 6 months

    Time frame: 6 months

  6. Change in UCLA Loneliness Scale from randomization to 6 months

    Time frame: 6 months

  7. Total # of COPD Exacerbations

    Time frame: 6 months

  8. Total # of ED visits

    Time frame: 6 months

  9. Total # of Hospitalizations

    Time frame: 6 months

  10. Change in Modified Medical Research Council (mMRC) dyspnea scale from enrollment to 12 months - For Peer Coach subjects

    Time frame: 12 months

  11. Change in Clinical COPD Questionnaire (CCQ) from enrollment to 12 months- For Peer Coach subjects

    Time frame: 12 months

  12. Change in Activation (Self Efficacy for Managing Chronic Diseases 6) from enrollment to 12 months - For Peer Coach subjects

    Time frame: 12 months

  13. Change in Hospital Anxiety and Depression Scale (HADS) from enrollment to 12 months - For Peer Coach subjects

    Time frame: 12 months

  14. Change in UCLA Loneliness Scale from enrollment to 12 months - For Peer Coach subjects

    Time frame: 12 months

  15. Change in Satisfaction with life scale (SWLS) from enrollment to 12 months - For Peer Coach subjects

    Time frame: 12 months

  16. Breathlessness belief questionnaire

    11-item scale to measure activity avoidance due to dyspnea.

    Time frame: 6-months.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — We will share deidentified individual participant data upon receipt and approval of research question and analysis plan from a researcher; or for teaching purposes.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: We will share deidentified IPD based on our criteria within 3 months after publication of our study results in scientific journals without any time limit to share thereafter.

Access criteria: Access will be based on receipt of research question/s and analysis strategies planned by a researcher. Approval to access the deidentified IDP will be granted to the researcher if deemed relevant by the study PI.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05399056
Lead sponsor
Baystate Medical Center
Responsible party
Sponsor
First posted
Jun 1, 2022
Start date
Feb 24, 2023
Primary completion
Jul 30, 2026 (estimated)
Completion
Jan 31, 2027 (estimated)
Last update
Jun 5, 2026

Study contacts

Rajashree Kotejoshyer, ScD
Contact
Rajashree.Kotejoshyer@baystatehealth.org
978-761-8709
Jennifer Hazelton
Contact
jennifer.hazelton@umassmed.edu
978-337-0340
Peter Lindenauer, MD, MSc
principal investigator · Baystate Health

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion